跳至主要内容
临床试验/NCT04325165
NCT04325165撤回不适用

Deep Brain Stimulation (DBS) of the Pedunculopontine Nucleus (PPN) to Improve Walking in Chronic Spinal Cord Injury (SCI) Patients

University Health Network, Toronto0 个研究点开始时间: 2015年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Walk assessment

研究概览

简要总结

Spinal cord injury (SCI) is a devastating condition affecting over 1 million individuals in North America. SCI often results in severe motor impairments with few available treatments options. Recent groundbreaking research has demonstrated that deep brain stimulation (DBS) of the mesencephalic locomotor region (MLR) greatly improves locomotion in a rat model with incomplete SCI. The pedunculopontine nucleus (PPN - a specific nucleus within the MLR) in humans has already been established as an auxillary DBS target in Parkinson Disease (PD), to improve motor control and locomotion. DBS of other targets has also been safely used in humans with SCI for chronic pain. These findings suggest that DBS of the PPN may have potential as a therapeutic intervention in the SCI population to improve locomotion. Our goal is to conduct a pioneering study in 5 select motor-incomplete chronic SCI patients that cannot functionally ambulate to examine if bilateral DBS of the PPN improves walking

详细描述

This prospective repeated measures study of the implantation of bilateral PPN electrodes in a small series of chronic SCI patients will aim to examine safety, feasibility, and potential efficacy. This research will investigate the effects of electrode implantation, electrical stimulation and intensive locomotion training over a 1-year period. Motor assessments will be performed at regular intervals with stimulation on and off in a double-blind fashion (subjects and researchers will be unaware of stimulation setting), to determine if subjects have improved ambulation with stimulation on compared with off, and if their ambulation improves over the course of the study observation period with stimulation on.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 65 (at time of enrolment)
  • SCI that occurred greater than 2 years ago
  • Current neurological status of AIS grade C or D, can stand with aids but not functionally ambulate
  • Residence in GTA

排除标准

  • Other substantial medical conditions causing physical restrictions, neurological deficits, or causing excessive risk of surgery
  • Professional or other time commitments affecting availability for numerous hospital visits
  • Contraindications to MRI (eg. metal in eye)
  • Women that are pregnant (according to a bHCG serum/urine test at time of screening), or are actively seeking to become pregnant

结局指标

主要结局

Walk assessment

时间窗: 1 Year

Patients are assess by how a person walks or move their limbs. Patients will be asked to walk on a mat while the system captures gait patterns for both time (temporal) and space (spatial) through pressure sensors in a mat located in a walkway.

Timed 10-meter walk test

时间窗: 1 year

Patients are assess by walking speed in metres per second over a 10-metre walk distance.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andres M. Lozano

Professor and Chairman, Dan Family Chair in Neurosurgery

University Health Network, Toronto

相似试验

DBS of PPN to Improve Walking in Chronic SCI Patients | 临床试验